http://phys.org/ en-us Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. (AP) -- A Massachusetts woman who withheld at-home chemotherapy medications from her autistic, cancer-stricken son was convicted of attempted murder Tuesday by jurors who dismissed her claim that she thought the side effects of the treatment could kill him. http://phys.org/news221836570.html Medicine & Health Tue, 12 Apr 2011 14:16:24 EST news221836570 The American College of Rheumatology today announced the release of two new provisional definitions of rheumatoid arthritis remission, which are to be applied to future RA clinical trials. http://phys.org/news215954622.html Medicine & Health Thu, 03 Feb 2011 11:40:02 EST news215954622 Arsenic, a toxic compound with a reputation as a good tool for committing homicide, has a significant positive effect on the survival of patients with acute promyelocytic leukemia (APL), when administered after standard initial treatment, according to a new, multi-center study led by a researcher at Wake Forest University Baptist Medical Center. http://phys.org/news208704590.html Medicine & Health Thu, 11 Nov 2010 13:30:14 EST news208704590 In a comparison of treatments for maintaining remission of a certain type of vasculitis (inflammation of blood vessels), the immunosuppressant mycophenolate mofetil, regarded as an alternative to the drug often used to prevent relapse, azathioprine, was less effective, according to a study that will appear in the December 1 print edition of JAMA. The study is being released early online to coincide with its presentation at the American College of Rheumatology annual scientific meeting. http://phys.org/news208459777.html Medicine & Health Mon, 08 Nov 2010 17:30:32 EST news208459777 A discovery made by Lupus Research Institute-funded investigator Emily Baechler Gillespie, PhD, at the University of Minnesota has been licensed to a major clinical laboratory for development and could soon result in a test that quickly and easily enables patients and their physicians to determine when a lupus flare is imminent. http://phys.org/news207494218.html Medicine & Health Thu, 28 Oct 2010 14:40:05 EST news207494218 (PhysOrg.com) -- New medical trials suggest some chronic leukemia patients who are in complete remission may be cured by the standard drug used to treat the condition and can safely discontinue its use. http://phys.org/news206857320.html Medicine & Health Thu, 21 Oct 2010 07:30:01 EST news206857320 Biological agents may play an important role in maintaining remission in Crohn's disease, according to two new studies in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. http://phys.org/news200227230.html Medicine & Health Thu, 05 Aug 2010 11:40:44 EST news200227230 Achieving disease remission in patients with rheumatoid arthritis (RA) provides superior outcomes across measures of socio-economic importance including work productivity and quality of life according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. These Austrian findings are reported in addition to improvements in measures of physical functioning, when compared with RA patients achieving low disease activity (LDA). http://phys.org/news196090840.html Medicine & Health Sat, 19 Jun 2010 03:00:02 EST news196090840 During pregnancy, many women experience remission of autoimmune diseases like multiple sclerosis and uveitis. Now, scientists have described a biological mechanism responsible for changes in the immune system that helps to explain the remission. http://phys.org/news195969919.html Medicine & Health Thu, 17 Jun 2010 05:08:21 EST news195969919 A study conducted by researchers in The Netherlands confirmed that children with idiopathic new-onset epilepsy have a significantly higher rate of remission than those with remote symptomatic epilepsy. Results of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy. http://phys.org/news195658412.html Medicine & Health Mon, 14 Jun 2010 00:00:03 EST news195658412 Long-term treatment with anti-cancer medication Rituxan, produced by Swiss laboratory Roche, can cut the recurrence of follicular lymphoma in some patients by half, a new study said. http://phys.org/news193633010.html Medicine & Health Fri, 21 May 2010 04:10:01 EST news193633010 Clinicians rely on laboratory tests to monitor the progression or remission of disease, or to identify pathologic alterations in physiology that may precede clinical events. Monitoring quantitative laboratory results represents a crucial component in the assessment of response to therapy. Researchers at Boston University School of Medicine (BUSM) have developed a mathematical methodology to reduce the effect of biologic variation on the difference necessary to detect changes in clinical status. The findings, which appear in the January issue of Archives of Pathology & Laboratory Medicine, may lead to better patient predictions at a lower cost. http://phys.org/news182000755.html Medicine & Health Wed, 06 Jan 2010 11:47:18 EST news182000755 In the first trial of its kind in the world, researchers at Monash University's Centre for Obesity Research and Education (CORE) will examine the benefits of a gastric banding procedure on overweight people with Type 2 diabetes. http://phys.org/news174735454.html Medicine & Health Wed, 14 Oct 2009 10:57:52 EST news174735454 (AP) -- Adults with a common form of leukemia had a better chance of remission if they got a double dose of a long-used cancer drug, two new studies found. http://phys.org/news172947904.html Medicine & Health Wed, 23 Sep 2009 18:05:50 EST news172947904 Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. http://phys.org/news170494244.html Medicine & Health Wed, 26 Aug 2009 08:31:24 EST news170494244 A clinical trial of masitinib, a drug in development for the treatment of rheumatoid arthritis, has shown it to be well tolerated and effective. Researchers writing in BioMed Central's open access journal Arthritis Research and Therapy have shown that treatment with masitinib significantly reduced the severity of active arthritis. http://phys.org/news165296111.html Medicine & Health Sat, 27 Jun 2009 04:36:39 EST news165296111 A new treatment using a combination of drugs targeting different parts of the immune system improves the recovery rate for patients with severe lupus involving the kidneys, according to a report in the October Journal of the American Society of Nephrology (JASN). http://phys.org/news134197111.html Medicine & Health Wed, 02 Jul 2008 05:58:31 EST news134197111